<DOC>
	<DOCNO>NCT01401387</DOCNO>
	<brief_summary>This study evaluate effect immediate pancreatic enzyme suppletion physical mental health status survival patient diagnose pancreatic cancer highly likely develop exocrine pancreatic insufficiency disease process .</brief_summary>
	<brief_title>Pancreatic Enzyme Suppletion Pancreatic Cancer</brief_title>
	<detailed_description>Weight loss cancer cause primary tumour effect secondary effect ( e.g . side effect treatment , mechanical intestinal obstruction ) . In pancreatic cancer , additional weight loss malnutrition may due development exocrine pancreatic insufficiency ( EPI ) . The presence EPI pancreatic cancer frequently overlook , focus treatment direct possible surgery chemotherapy potential side effect . Although study proven pancreatic enzyme may prevent decrease weight loss , seldom prescribe .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Adenocarcinoma pancreas ( histologically confirm ) Normal exocrine pancreatic function ( Fecal Elastase test &gt; 0.2 mg/g ) Capable willing follow instruction give physician . Other cause fat malabsorption ( celiac disease , IBD , major gastrointestinal surgery ) . &lt; 18 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>